TRIMIPRAMINE MALEATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for trimipramine maleate and what is the scope of patent protection?
Trimipramine maleate
is the generic ingredient in two branded drugs marketed by Odyssey Pharms, Breckenridge, Elite Labs Inc, and Usl Pharma, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.There are five drug master file entries for trimipramine maleate. Three suppliers are listed for this compound.
Summary for TRIMIPRAMINE MALEATE
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 4 |
| NDAs: | 6 |
| Drug Master File Entries: | 5 |
| Finished Product Suppliers / Packagers: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 59 |
| Patent Applications: | 955 |
| Drug Prices: | Drug price trends for TRIMIPRAMINE MALEATE |
| What excipients (inactive ingredients) are in TRIMIPRAMINE MALEATE? | TRIMIPRAMINE MALEATE excipients list |
| DailyMed Link: | TRIMIPRAMINE MALEATE at DailyMed |
Pharmacology for TRIMIPRAMINE MALEATE
| Drug Class | Tricyclic Antidepressant |
Medical Subject Heading (MeSH) Categories for TRIMIPRAMINE MALEATE
Anatomical Therapeutic Chemical (ATC) Classes for TRIMIPRAMINE MALEATE
US Patents and Regulatory Information for TRIMIPRAMINE MALEATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elite Labs Inc | TRIMIPRAMINE MALEATE | trimipramine maleate | CAPSULE;ORAL | 077361-001 | Aug 2, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Odyssey Pharms | SURMONTIL | trimipramine maleate | CAPSULE;ORAL | 016792-003 | Sep 15, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Elite Labs Inc | TRIMIPRAMINE MALEATE | trimipramine maleate | CAPSULE;ORAL | 077361-003 | Aug 2, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Breckenridge | TRIMIPRAMINE MALEATE | trimipramine maleate | CAPSULE;ORAL | 208127-002 | Apr 15, 2016 | AB | RX | No | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Usl Pharma | TRIMIPRAMINE MALEATE | trimipramine maleate | CAPSULE;ORAL | 071283-001 | Dec 8, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
